Remicade Drug Market
1 Study Coverage
1.1 Remicade (infliximab) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Remicade (infliximab) Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Remicade (infliximab) Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Remicade (infliximab) Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Remicade (infliximab) Drug Sales by Region
2.4.1 Global Remicade (infliximab) Drug Sales by Region (2017-2022)
2.4.2 Global Sales Remicade (infliximab) Drug by Region (2023-2028)
2.5 Global Remicade (infliximab) Drug Revenue by Region
2.5.1 Global Remicade (infliximab) Drug Revenue by Region (2017-2022)
2.5.2 Global Remicade (infliximab) Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Remicade (infliximab) Drug Sales by Manufacturers
3.1.1 Global Top Remicade (infliximab) Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Remicade (infliximab) Drug in 2021
3.2 Global Remicade (infliximab) Drug Revenue by Manufacturers
3.2.1 Global Remicade (infliximab) Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Remicade (infliximab) Drug Revenue in 2021
3.3 Global Remicade (infliximab) Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Remicade (infliximab) Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Remicade (infliximab) Drug Sales by Type
4.1.1 Global Remicade (infliximab) Drug Historical Sales by Type (2017-2022)
4.1.2 Global Remicade (infliximab) Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
4.2 Global Remicade (infliximab) Drug Revenue by Type
4.2.1 Global Remicade (infliximab) Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Remicade (infliximab) Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
4.3 Global Remicade (infliximab) Drug Price by Type
4.3.1 Global Remicade (infliximab) Drug Price by Type (2017-2022)
4.3.2 Global Remicade (infliximab) Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Remicade (infliximab) Drug Sales by Application
5.1.1 Global Remicade (infliximab) Drug Historical Sales by Application (2017-2022)
5.1.2 Global Remicade (infliximab) Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
5.2 Global Remicade (infliximab) Drug Revenue by Application
5.2.1 Global Remicade (infliximab) Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Remicade (infliximab) Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
5.3 Global Remicade (infliximab) Drug Price by Application
5.3.1 Global Remicade (infliximab) Drug Price by Application (2017-2022)
5.3.2 Global Remicade (infliximab) Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Remicade (infliximab) Drug Market Size by Type
6.1.1 North America Remicade (infliximab) Drug Sales by Type (2017-2028)
6.1.2 North America Remicade (infliximab) Drug Revenue by Type (2017-2028)
6.2 North America Remicade (infliximab) Drug Market Size by Application
6.2.1 North America Remicade (infliximab) Drug Sales by Application (2017-2028)
6.2.2 North America Remicade (infliximab) Drug Revenue by Application (2017-2028)
6.3 North America Remicade (infliximab) Drug Market Size by Country
6.3.1 North America Remicade (infliximab) Drug Sales by Country (2017-2028)
6.3.2 North America Remicade (infliximab) Drug Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Remicade (infliximab) Drug Market Size by Type
7.1.1 Europe Remicade (infliximab) Drug Sales by Type (2017-2028)
7.1.2 Europe Remicade (infliximab) Drug Revenue by Type (2017-2028)
7.2 Europe Remicade (infliximab) Drug Market Size by Application
7.2.1 Europe Remicade (infliximab) Drug Sales by Application (2017-2028)
7.2.2 Europe Remicade (infliximab) Drug Revenue by Application (2017-2028)
7.3 Europe Remicade (infliximab) Drug Market Size by Country
7.3.1 Europe Remicade (infliximab) Drug Sales by Country (2017-2028)
7.3.2 Europe Remicade (infliximab) Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Remicade (infliximab) Drug Market Size by Type
8.1.1 Asia Pacific Remicade (infliximab) Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Remicade (infliximab) Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Remicade (infliximab) Drug Market Size by Application
8.2.1 Asia Pacific Remicade (infliximab) Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Remicade (infliximab) Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Remicade (infliximab) Drug Market Size by Region
8.3.1 Asia Pacific Remicade (infliximab) Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Remicade (infliximab) Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Remicade (infliximab) Drug Market Size by Type
9.1.1 Latin America Remicade (infliximab) Drug Sales by Type (2017-2028)
9.1.2 Latin America Remicade (infliximab) Drug Revenue by Type (2017-2028)
9.2 Latin America Remicade (infliximab) Drug Market Size by Application
9.2.1 Latin America Remicade (infliximab) Drug Sales by Application (2017-2028)
9.2.2 Latin America Remicade (infliximab) Drug Revenue by Application (2017-2028)
9.3 Latin America Remicade (infliximab) Drug Market Size by Country
9.3.1 Latin America Remicade (infliximab) Drug Sales by Country (2017-2028)
9.3.2 Latin America Remicade (infliximab) Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Remicade (infliximab) Drug Market Size by Type
10.1.1 Middle East and Africa Remicade (infliximab) Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Remicade (infliximab) Drug Market Size by Application
10.2.1 Middle East and Africa Remicade (infliximab) Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Remicade (infliximab) Drug Market Size by Country
10.3.1 Middle East and Africa Remicade (infliximab) Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen
11.1.1 Janssen Corporation Information
11.1.2 Janssen Overview
11.1.3 Janssen Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Recent Developments
11.2 Hospira
11.2.1 Hospira Corporation Information
11.2.2 Hospira Overview
11.2.3 Hospira Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hospira Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hospira Recent Developments
11.3 Celltrion Healthcare
11.3.1 Celltrion Healthcare Corporation Information
11.3.2 Celltrion Healthcare Overview
11.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celltrion Healthcare Recent Developments
11.4 Epirus Biopharmaceuticals
11.4.1 Epirus Biopharmaceuticals Corporation Information
11.4.2 Epirus Biopharmaceuticals Overview
11.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epirus Biopharmaceuticals Recent Developments
11.5 Samsung Bioepsis
11.5.1 Samsung Bioepsis Corporation Information
11.5.2 Samsung Bioepsis Overview
11.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Samsung Bioepsis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Remicade (infliximab) Drug Industry Chain Analysis
12.2 Remicade (infliximab) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Remicade (infliximab) Drug Production Mode & Process
12.4 Remicade (infliximab) Drug Sales and Marketing
12.4.1 Remicade (infliximab) Drug Sales Channels
12.4.2 Remicade (infliximab) Drug Distributors
12.5 Remicade (infliximab) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Remicade (infliximab) Drug Industry Trends
13.2 Remicade (infliximab) Drug Market Drivers
13.3 Remicade (infliximab) Drug Market Challenges
13.4 Remicade (infliximab) Drug Market Restraints
14 Key Findings in The Global Remicade (infliximab) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Remicade (infliximab) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Brands Drugs
Table 3. Major Manufacturers of Generic Drugs
Table 4. Global Remicade (infliximab) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Remicade (infliximab) Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Remicade (infliximab) Drug Sales by Region (2017-2022) & (K Units)
Table 7. Global Remicade (infliximab) Drug Sales Market Share by Region (2017-2022)
Table 8. Global Remicade (infliximab) Drug Sales by Region (2023-2028) & (K Units)
Table 9. Global Remicade (infliximab) Drug Sales Market Share by Region (2023-2028)
Table 10. Global Remicade (infliximab) Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Remicade (infliximab) Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Remicade (infliximab) Drug Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Remicade (infliximab) Drug Revenue Market Share by Region (2023-2028)
Table 14. Global Remicade (infliximab) Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Remicade (infliximab) Drug Sales Share by Manufacturers (2017-2022)
Table 16. Global Remicade (infliximab) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2017-2022)
Table 18. Remicade (infliximab) Drug Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Remicade (infliximab) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Remicade (infliximab) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remicade (infliximab) Drug as of 2021)
Table 21. Remicade (infliximab) Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Remicade (infliximab) Drug Product Offered
Table 23. Date of Manufacturers Enter into Remicade (infliximab) Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 26. Global Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 27. Global Remicade (infliximab) Drug Sales Share by Type (2017-2022)
Table 28. Global Remicade (infliximab) Drug Sales Share by Type (2023-2028)
Table 29. Global Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Remicade (infliximab) Drug Revenue Share by Type (2017-2022)
Table 32. Global Remicade (infliximab) Drug Revenue Share by Type (2023-2028)
Table 33. Remicade (infliximab) Drug Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Remicade (infliximab) Drug Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 36. Global Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 37. Global Remicade (infliximab) Drug Sales Share by Application (2017-2022)
Table 38. Global Remicade (infliximab) Drug Sales Share by Application (2023-2028)
Table 39. Global Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Remicade (infliximab) Drug Revenue Share by Application (2017-2022)
Table 42. Global Remicade (infliximab) Drug Revenue Share by Application (2023-2028)
Table 43. Remicade (infliximab) Drug Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Remicade (infliximab) Drug Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 46. North America Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 47. North America Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 50. North America Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 51. North America Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
Table 54. North America Remicade (infliximab) Drug Sales by Country (2023-2028) & (K Units)
Table 55. North America Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Remicade (infliximab) Drug Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 58. Europe Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 59. Europe Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 62. Europe Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 63. Europe Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
Table 66. Europe Remicade (infliximab) Drug Sales by Country (2023-2028) & (K Units)
Table 67. Europe Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Remicade (infliximab) Drug Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Remicade (infliximab) Drug Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Remicade (infliximab) Drug Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Remicade (infliximab) Drug Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Remicade (infliximab) Drug Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Remicade (infliximab) Drug Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Remicade (infliximab) Drug Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Remicade (infliximab) Drug Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Remicade (infliximab) Drug Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2023-2028) & (US$ Million)
Table 105. Janssen Corporation Information
Table 106. Janssen Description and Major Businesses
Table 107. Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Janssen Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Janssen Recent Developments
Table 110. Hospira Corporation Information
Table 111. Hospira Description and Major Businesses
Table 112. Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Hospira Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Hospira Recent Developments
Table 115. Celltrion Healthcare Corporation Information
Table 116. Celltrion Healthcare Description and Major Businesses
Table 117. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Celltrion Healthcare Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Celltrion Healthcare Recent Developments
Table 120. Epirus Biopharmaceuticals Corporation Information
Table 121. Epirus Biopharmaceuticals Description and Major Businesses
Table 122. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Epirus Biopharmaceuticals Recent Developments
Table 125. Samsung Bioepsis Corporation Information
Table 126. Samsung Bioepsis Description and Major Businesses
Table 127. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Samsung Bioepsis Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Samsung Bioepsis Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Remicade (infliximab) Drug Distributors List
Table 133. Remicade (infliximab) Drug Customers List
Table 134. Remicade (infliximab) Drug Market Trends
Table 135. Remicade (infliximab) Drug Market Drivers
Table 136. Remicade (infliximab) Drug Market Challenges
Table 137. Remicade (infliximab) Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Remicade (infliximab) Drug Product Picture
Figure 3. Global Remicade (infliximab) Drug Market Share by Type in 2021 & 2028
Figure 3. Brands Drugs Product Picture
Figure 4. Generic Drugs Product Picture
Figure 5. Global Remicade (infliximab) Drug Market Share by Application in 2021 & 2028
Figure 6. Crohn's Disease
Figure 7. Pediatric Crohn's Disease
Figure 8. Ulcerative Colitis
Figure 9. Pediatric Ulcerative Colitis
Figure 10. Other
Figure 11. Remicade (infliximab) Drug Report Years Considered
Figure 12. Global Remicade (infliximab) Drug Sales 2017-2028 (K Units)
Figure 13. Global Remicade (infliximab) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Remicade (infliximab) Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Remicade (infliximab) Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Remicade (infliximab) Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Remicade (infliximab) Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Remicade (infliximab) Drug Sales YoY (2017-2028) & (K Units)
Figure 19. North America Remicade (infliximab) Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Remicade (infliximab) Drug Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Remicade (infliximab) Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Remicade (infliximab) Drug Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Remicade (infliximab) Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Remicade (infliximab) Drug Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Remicade (infliximab) Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Remicade (infliximab) Drug Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Remicade (infliximab) Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Remicade (infliximab) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Remicade (infliximab) Drug in the World: Market Share by Remicade (infliximab) Drug Revenue in 2021
Figure 30. Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Remicade (infliximab) Drug Sales Share by Country (2017-2028)
Figure 40. North America Remicade (infliximab) Drug Revenue Share by Country (2017-2028)
Figure 41. the United States Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Remicade (infliximab) Drug Sales Share by Country (2017-2028)
Figure 48. Europe Remicade (infliximab) Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 51. UK Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Remicade (infliximab) Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Remicade (infliximab) Drug Revenue Share by Region (2017-2028)
Figure 60. China Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 70. Latin America Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 72. Latin America Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Remicade (infliximab) Drug Sales Share by Country (2017-2028)
Figure 74. Latin America Remicade (infliximab) Drug Revenue Share by Country (2017-2028)
Figure 75. Mexico Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Remicade (infliximab) Drug Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Remicade (infliximab) Drug Revenue Share by Country (2017-2028)
Figure 84. Turkey Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Remicade (infliximab) Drug Revenue (2017-2028) & (US$ Million)
Figure 87. Remicade (infliximab) Drug Value Chain
Figure 88. Remicade (infliximab) Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
